Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

334.38 +0.40 (+0.12%)
Streaming Delayed Price Updated: 9:58 AM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Earnings Scheduled For October 31, 2022
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion. 
Via Benzinga
Where Stryker Stands With Analysts
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter: 
Via Benzinga
Expert Ratings for Stryker
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter: 
Via Benzinga
Analyst Ratings for Stryker
Within the last quarter, Stryker (NYSE:SYK) has observed the following analyst ratings: 
Via Benzinga
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
Plus a look at investing books, stocks to watch, and other topics for investors. 
Via The Motley Fool
Stryker's Earnings Outlook
Stryker (NYSE:SYK) is set to give its latest quarterly earnings report on Monday, 2022-10-31. Here's what investors need to know before the announcement. Analysts estimate that Stryker will report an... 
Via Benzinga
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. 
Via MarketBeat
Topics ETFs Initial Public Offering
Exposures Securities Market
3 Medical Stocks On the Rebound
As surgeries bounce back toward pre-pandemic levels, these three companies should benefit. 
Via The Motley Fool
Stryker Unveils New Gamma4 Hip Fracture Nailing System
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
From Stryker
Via Business Wire
Analyzing Stryker's Short Interest
Stryker's (NYSE:SYK) short percent of float has risen 25.0% since its last report. The company recently reported that it has 6.49 million shares sold short, which is 1.85% of all regular shares that... 
Via Benzinga
2 Healthcare Stocks That Could Help Make You a Fortune
If given enough time, these two stocks can do the heavy lifting in building wealth for you. 
Via The Motley Fool
This Savvy Congressman Is Making Trades Under His Kid's Name: Check Out 2 Dividend Stocks He Owns
Democratic Congressman Ro Khanna has made more than 13,000 trades in the past three years. The U.S. representative from California is considered one of the most active traders in Congress, according to... 
Via Benzinga
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
From Stryker
Via Business Wire
Stryker to host conference call on October 31, 2022
From Stryker Corporation
Via GlobeNewswire
Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Years
Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 1.36% on an annualized basis producing an average annual return of 7.12%. Currently, Stryker has a market capitalization of... 
Via Benzinga
Stryker Launches Q Guidance System with Spine Guidance Software
From Stryker
Via Business Wire
3 Undervalued Dividend Champions With High Return Potential
These dividend stocks have potential to generate high returns for income investors. Let's take a closer look at three dividend champions. 
Via InvestorPlace
Piper Sandler Maintains Overweight Rating for Stryker: Here's What You Need To Know
Piper Sandler has decided to maintain its Overweight rating of Stryker (NYSE:SYK) and raise its price target from $250.00 to $260.00. Shares of Stryker are trading down 0.19% over the last 24 hours, at... 
Via Benzinga
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... 
Via Benzinga
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting
From Stryker
Via Business Wire
Disney, GM Got Are CNBC 'Fast Money' Mentions; Jon Najarian Sees Unusual Options Activity In These Stocks
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Stryker Launches New Gamma4 Hip Fracture Nailing System
From Stryker
Via Business Wire
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat. 
Via Investor's Business Daily
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,000 Today
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 3.08% on an annualized basis producing an average annual return of 11.07%. Currently, Stryker has a market capitalization of... 
Via Benzinga
Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review
The major indexes made big moves amid key earnings and another big Fed rate hike. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
  
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.